A detailed history of Us Bancorp \De\ transactions in Novartis Ag stock. As of the latest transaction made, Us Bancorp \De\ holds 242,627 shares of NVS stock, worth $26.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
242,627
Previous 216,477 12.08%
Holding current value
$26.8 Million
Previous $23 Million 21.09%
% of portfolio
0.04%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$106.13 - $120.89 $2.78 Million - $3.16 Million
26,150 Added 12.08%
242,627 $27.9 Million
Q2 2024

Aug 06, 2024

SELL
$92.57 - $107.37 $4.41 Million - $5.11 Million
-47,599 Reduced 18.02%
216,477 $23 Million
Q1 2024

May 07, 2024

SELL
$95.27 - $108.47 $235,031 - $267,595
-2,467 Reduced 0.93%
264,076 $25.5 Million
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $2.9 Million - $3.19 Million
31,452 Added 13.38%
266,543 $26.9 Million
Q3 2023

Nov 03, 2023

BUY
$94.73 - $105.13 $2.55 Million - $2.83 Million
26,946 Added 12.95%
235,091 $23.9 Million
Q2 2023

Aug 09, 2023

BUY
$92.52 - $104.91 $326,318 - $370,017
3,527 Added 1.72%
208,145 $21 Million
Q1 2023

May 09, 2023

SELL
$80.03 - $92.81 $2.18 Million - $2.53 Million
-27,261 Reduced 11.76%
204,618 $18.8 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $3.06 Million - $3.75 Million
40,537 Added 21.19%
231,879 $21 Million
Q3 2022

Oct 27, 2022

SELL
$74.61 - $87.26 $5 Million - $5.84 Million
-66,954 Reduced 25.92%
191,342 $14.5 Million
Q2 2022

Aug 01, 2022

BUY
$80.52 - $93.75 $1.73 Million - $2.01 Million
21,434 Added 9.05%
258,296 $21.8 Million
Q1 2022

May 11, 2022

SELL
$80.11 - $90.62 $841,956 - $952,416
-10,510 Reduced 4.25%
236,862 $20.8 Million
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $4.54 Million - $5.02 Million
-56,933 Reduced 18.71%
247,372 $21.6 Million
Q3 2021

Nov 10, 2021

SELL
$81.78 - $95.14 $1.58 Million - $1.84 Million
-19,316 Reduced 5.97%
304,305 $24.9 Million
Q2 2021

Aug 05, 2021

BUY
$85.24 - $94.15 $1.66 Million - $1.83 Million
19,444 Added 6.39%
323,621 $29.5 Million
Q1 2021

Apr 28, 2021

BUY
$83.5 - $98.47 $718,601 - $847,432
8,606 Added 2.91%
304,177 $26 Million
Q4 2020

Feb 04, 2021

BUY
$78.07 - $94.43 $588,335 - $711,624
7,536 Added 2.62%
295,571 $27.9 Million
Q3 2020

Nov 10, 2020

SELL
$82.14 - $91.0 $2.26 Million - $2.5 Million
-27,503 Reduced 8.72%
288,035 $25 Million
Q2 2020

Aug 07, 2020

SELL
$80.93 - $91.1 $445,519 - $501,505
-5,505 Reduced 1.71%
315,538 $27.6 Million
Q1 2020

May 13, 2020

BUY
$70.67 - $99.01 $5.53 Million - $7.74 Million
78,210 Added 32.21%
321,043 $26.5 Million
Q4 2019

Feb 04, 2020

BUY
$84.35 - $95.37 $414,158 - $468,266
4,910 Added 2.06%
242,833 $23 Million
Q3 2019

Nov 08, 2019

BUY
$85.54 - $94.26 $3.58 Million - $3.95 Million
41,876 Added 21.36%
237,923 $20.7 Million
Q2 2019

Aug 13, 2019

SELL
$75.4 - $92.8 $2.33 Million - $2.86 Million
-30,850 Reduced 13.6%
196,047 $17.9 Million
Q1 2019

May 08, 2019

SELL
$75.32 - $86.15 $5.05 Million - $5.77 Million
-67,031 Reduced 22.81%
226,897 $21.8 Million
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $3.35 Million - $3.73 Million
45,434 Added 18.28%
293,928 $25.2 Million
Q3 2018

Nov 01, 2018

BUY
$66.94 - $77.43 $1.93 Million - $2.23 Million
28,850 Added 13.13%
248,494 $21.4 Million
Q2 2018

Aug 08, 2018

BUY
$64.91 - $73.36 $779,504 - $880,980
12,009 Added 5.78%
219,644 $16.6 Million
Q1 2018

May 08, 2018

SELL
$70.39 - $84.15 $2.28 Million - $2.72 Million
-32,376 Reduced 13.49%
207,635 $16.8 Million
Q4 2017

Feb 02, 2018

BUY
$72.33 - $77.64 $1.5 Million - $1.61 Million
20,778 Added 9.48%
240,011 $20.2 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $16.3 Million - $16.9 Million
219,233
219,233 $18.8 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.